Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome

Kadioglu, A; Tefekli, A; Koksal, T; Usta, M; Erol, H

doi:10.1038/sj.ijir.3900519

Treatment of Peyronie's disease with oral colchicine: long-term results and predictive parameters of successful outcome

Copy For Citation

Kadioglu A., Tefekli A., Koksal T., Usta M., Erol H.

INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, vol.12, no.3, pp.169-175, 2000 (SCI-Expanded)

Publication Type: Article / Article
Volume: 12 Issue: 3
Publication Date: 2000
Doi Number: 10.1038/sj.ijir.3900519
Journal Name: INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.169-175
Istanbul University Affiliated: No

Abstract

As recent clinical and animal studies have indicated, colchicine, with its anti-fibrotic, anti-mitotic and anti-inflammatory activities, has suppressive effects in the pathogenesis of Peyronie's disease.